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ABSTRACT: Degradable magnesium alloys are new materials for implants
used in orthopedic and trauma surgery. The aim of this study was to investigate
the influence of degradable magnesium alloys on the function of dendritic cells
(DC) as these cells represent the major antigen presenting cells of the body.
MgP (pure magnesium), MgCa 0.6 (0.6% calcium), MgCa 0.8 (0.8% calcium),
MgCa 1.0 (1% calcium), and MgCa 1.2 (1.2% calcium) alloys were degraded in
cell culture medium. In parallel, murine bone marrow-derived DC were
incubated with increasing concentrations (0.1–10mmol/L) of magnesium
chloride and calcium chloride, respectively. Incubation of DC with degradation
media over 6 days had no influence on cell viability and only marginal influence
on DC migration. Also, the production of TNFa and expression of CD86 was
not enhanced by incubation with degraded magnesium alloys. The mixed
leukocyte reaction revealed that there was also no increase of the T-cell
proliferation in comparison to untreated controls. However, there was a trend
toward macrophage development at the expense of DC expansion and
an enhanced DC migration was induced by incubation with higher
magnesium concentrations. Particularly the latter should be verified in in vivo
experiments.
KEY WORDS: dendritic cells, macrophages, magnesium alloys, T-cell activa-
tion, viability.
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INTRODUCTION
Degradable metal implants made of magnesium alloys are underdevelopment to eliminate the need for a second operation for
implant removal. Although magnesium is an exceptionally lightweight
metal its fracture toughness is greater than ceramic biomaterials such
as hydroxyapatite [1]. Though good biocompatibility was observed [1] a
possible interaction of degraded material with immunocompetent cells,
particularly professional antigen presenting cells, has not been studied
yet. There is a definite need to test possible new implant candidates for
biocompatibility and first studies dealing with a possible skin sensitizing
potential of new alloys have recently been published [2]. A study of skin
sensitizing potential was conducted as despite a continuous development
in implant materials, contact dermatitis after musculoskeletal surgery is
still apparent in 10–15% of all implanted metals [3].
The implants tested in the presented in vitro study have been tested in
a pilot study in rabbits and some alloys showed promising first results
for bone implantation [4]. These findings are confirmed by a recent
report on the excellent biocompatibility of Mg–Ca alloys within bones
[5]. Magnesium-based alloys are also combined with aluminum, zinc,
and rare earth elements to modify degradation behavior of implants [6].
Thus, these degradable implants need an in vitro biocompatibility test
system for possible immunomodulatory action of these alloys.
Up till now, most studies concerning possible sensitizing potential of
implants have been performed in vivo [3,6] or focused on lymphocytes
[7,8] and macrophages [9]. Possible effects of some metal salts have also
been tested in vitro in human monocyte-derived dendritic cells (DC).
It was demonstrated that NiCl2, MnCl2, and MoCl2 augment the TNFa
secretion and/or CD86 expression on DC [10]. Thus, some of the
frequently used metals for implant alloys have the potential to stimulate
DC. This is confirmed by studies with macrophages, where particles
of TiAlV or CoCr induce the secretion of several cytokines like TNFa,
IL-1b, IL-6, and IL-8 in human macrophages. Not only particles, but also
fully dissolved salts of nickel, molybdenum, and chromium induce
cytokine secretion in macrophages [11] indicating that the solid state
(particulate) is not a prerequisite of activating antigen presenting cells
like DC and macrophages.
This study was performed to introduce a new in vitro testing battery
for possible immunotoxicological effects of newly generated magnesium
alloys by means of DC function and dendritic cell–T-cell interaction.
Since DC are the pivotal sentinels of the immune system as they can
induce immunity as well as tolerance [12,13], it was decided to focus on
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the function of these immune cells. The cells are currently evaluated as
in vitro alternatives for testing (skin-)sensitizing agents [14,15].
MATERIALS AND METHODS
Manufacture of Magnesium Alloys
Five different binary magnesium-based implant materials with
increasing calcium content (0, 0.6, 0.8, 1.0, and 1.2wt% Ca) were
produced at the Institute of Materials Science of the Leibniz University of
Hannover. The producing process contained the casting, followed by
extrusion and the machining to cylindrical specimens with a diameter of
8mm and a height of 2mm. The casting process (gravity die casting) was
carried out in an inert gas atmosphere with a crucible furnace. The follo-
wing extrusion with an 800 kN labor extrusion press was used to increase
the mechanical properties of the material. Due to occurring of the
dynamical recrystallization, a fine grained and homogenous microstruc-
ture was generated to improve the corrosion and degradation behavior.
Dendritic Cell Generation from Bone Marrow Cultures
High-purity bone marrow-derived DC were generated according to a
standard protocol established by Lutz et al. (1999) [16] with slight
modifications as previously described [17]. Briefly, bone marrow was
cultivated with RPMI 1640 (Biochrom, Berlin, Germany), 10% fetal calf
serum (Biochrom, Berlin, Germany), and 50 mmol/L 2-mercaptoethanol
(Sigma, Deisenhofen, Germany). The medium contained 20ng/mL
granulocyte–macrophage colony-stimulating factor (GM-CSF) (Sigma,
Deisenhofen, Germany). Fresh medium supplemented with GM-CSF
was added on days 3, 6, and 8. Analysis of the day-10 cell suspension by
flow cytometry demonstrated a high yield of CD11c and major
histocompatibility complex (MHC) class II-positive cells (antibodies
from Pharmingen, Hamburg, Germany).
Incubation with Magnesium/Calcium Salts and Alloys
Beginning with day-3 of cultivation the DC were placed in a 12-well
plate (4 105 cells per well) and incubated with increasing concentra-
tions (0.1–10mmol/L) of magnesium chloride and calcium chloride.
RPMI 1640 itself contains already 0.4mmol/L Mgþþ and 0.61mmol/L
Caþþ. The cell viability was determined by CellTiter AQueous
One Solution cell proliferation assay (Promega, Mannheim, Germany).
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Five different alloys were tested by degradation of the alloys in culture
medium over three days. The following alloys were tested: MgP (pure
magnesium), MgCa 0.6 (0.6% calcium), MgCa 0.8 (0.8% calcium), MgCa
1.0 (1% calcium), MgCa 1.2 (1.2% calcium). The concentration of Mgþþ
and Caþþ in degradation media was measured by Nanocolor Ha¨rte 20
(Macherey-Nagel, Du¨ren, Germany). The DCs were incubated with
degradation medium for 6 days. The buffer capacity of the RPMI 1640
media was sufficient to maintain the pH at 7.4.
The cell count of adherent (macrophages) and nonadherent cells (DC)
was performed with a hemocytometer. For enumeration of adherent
cells, cells were detached by trypsination.
As a positive control, a part of the cells were placed in a 96-well plate
(5 104 cells per well) at day-9 and were stimulated by the addition of
5mL lipopolysaccharide (LPS) (E. coli, O127 : B8, Sigma, Deisenhofen,
Germany) working solution (500ng/mL LPS, final concentration). The
supernatant was collected 24 h later and stored at 208C until deter-
mination of tumor necrosis factor (TNF)-a by enzyme-linked immuno-
sorbent assay (ELISA, DuoSet, R&D Systems, Wiesbaden, Germany).
For determination of apoptosis and necrosis, the DC were stained
using the Annexin V-FITC apoptosis detection kit (BD Bioscience,
Heidelberg, Germany). For a brief period the DCs were incubated with
Annexin V-FITC and propidium iodide according to the manufacturer’s
instructions, and 105 cells were analyzed by flow cytometry (Coulter
Epics XL, Beckmann, Krefeld, Germany with Expo 32 ADC Analysis). As
a positive control, the DCs were treated with etoposide (20 mg/mL,
Sigma) for 24h. The combination of Annexin V-FITC and propidium
iodide allows the differentiation of viable cells (negative for Annexin
V-FITC and propidium iodide), early apopotitic cells (positive for
Annexin V-FITC negative for propidium iodide), and necrotic cells
(positive for Annexin V-FITC and propidium iodide)
Three independent experiments were performed with each alloy and
salt concentration.
Mixed Leukocyte Reaction
T-cells were isolated from the spleen of female NMRImice, as described
earlier [18]. In short, spleen cells were incubated in an erythrocyte lysis
buffer for 5min followed by an enrichment of T-lymphocytes achieved by
adhesion of non-T-cells on cellþ Petri dishes. This leads to a purity of appro-
ximately 70%T-cells. T-cells were stainedwith 0.5 mmol/L carboxyfluores-
cein succinimidyl ester (CFSE) (molecular probes, invitrogen, Karlsruhe,
Germany) according to manufacturer’s protocol. The cells (1 105per well)
688 K. FESER ET AL.
were seeded in a U-bottom 96-well plate. DC (1 104, day-10 of culture)
were added and incubated for five additional days. After 5 days,
proliferation of T-cells was determined by flow cytometry.
Chemotaxis Assay for Bone Marrow-derived DC
Bone marrow-derived murine DC cultivated for 10 days with or
without addition of salts or degradation media were used for chemotaxis
assay. The chemotaxis assay was performed in a transwell system
(Greiner, Frickenhausen, Germany) with inserts pore size of 8mm.
2 105 cells were loaded onto the upper membrane. Migrated cells were
determined in the lower chamber 90min after incubation by means of a
hemocytometer (VWR). Lead (PbCl2, Merck, Darmstadt, Germany)
served as positive control.
RESULTS
Viability of Dendritic Cells
The viability of DC is not significantly affected by incubation with
increasing concentrations (0.1–10mmol/L) of magnesium chloride and
calcium chloride as determined by CellTiter AQueous One Solution cell
proliferation assay (data not shown). The Annexin V-FITC and
propidium iodide staining indicate that only high concentrations of
calcium chloride (10mmol/L) induce apoptosis comparable to the positive
control etoposide (20 mg/mL). There is a slight increase of apoptosis
induced by the degraded alloy media (Table 1). But this is modest
compared to the increase after incubation with etoposide or CaCl
10mmol/L. Corresponding to the results obtained with CellTiter
AQueous One Solution there was no increase of propidium iodide positive
cells (necrotic cells) compared to untreated controls in either setting (not
shown). Thus, only data of Annexin-staining are presented (Table 1).
Shift to Macrophage Development
Although no significant impact on cell viability was observed, the
absolute cell count of DC decreased dose dependently with increasing
concentrations (0.1–10mmol/L) of magnesium chloride and calcium
chloride. Apart from the DC, the second cell types generated by the used
protocol were adherent macrophages [16]. Thus, the amount of adherent
cells was also determined. An increased cell number of macrophages was
observed after incubation with increasing concentrations of magnesium
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(Figure 1(a) and (b)) and calcium (not shown) salts. A similar trend was
seen with the degraded alloys. With increasing calcium concentrations,
the amount of DC counted at day-10 decreased whereas the amount of
macrophages increased slightly but significantly (Figure 1(c) and (d)).
No Elevation of TNF by Incubation with Magnesium/Calcium
Salts or Alloys
Incubation with increasing concentrations (0.1–10mmol/L) of magne-
sium chloride and calcium chloride or with degraded alloy media did not
result in significantly enhanced TNFa secretion of DC. The positive
control LPS (500ng/mL) induced a tremendous secretion of TNFa 24h
after incubation (Table 2).
Expression of CD86 on dendritic cells after Incubation with
Magnesium/Calcium Salts or Alloys
The activation marker CD86 was not elevated on DC after incu-
bation with magnesium chloride and calcium chloride or with degraded
Table 1. Annexin V-FITC staining of dendritic cells and CFSE
staining of T-cells co-incubated with dendritic cell. Percent
represents gated % positive cells. As there was no increase of
propidium iodide positive cells, only Annexin V data are shown.
Etoposide (20g/mL) served as positive control for Annexin
V staining. Dendritic cells were incubated with increasing
concentration of MgCl2 and CaCl2 or with increasing degrada-
tion media, meanSD of three independent experiments.
ap50.05, bp50.01 compared to vehicle control.
Incubation with Annexin Vþ cells (%) CFSEþ cells (%)
Vehicle (control) 23.8 1.7 46.5 8.0
Etoposide 53.9 3.1b –
MgCl 0.1 mmol/L 20.5 3.3 51.7 10.1
MgCl 1 mmol/L 18.4 2.3 51.9 9.2
MgCl 10 mmol/L 20.0 2.8 52.3 2.3
CaCl 0.1 mmol/L 18.1 3.2 47.5 8.0
CaCl 1 mmol/L 20.9 4.2 52.0 7.0
CaCl 10 mmol/L 68.2 3.7b 72.9 6.8a
MgP 31.7 2.6a 48.9 8.3
MgCa 0.6 26.7 2.1 48.4 6.6
MgCa 0.8 23.4 3.2 47.4 5.6
MgCa 1.0 25.7 4.5 50.1 6.9
MgCa 1.2 23.9 2.2 52.6 6.5
690 K. FESER ET AL.
(a)
D
C 
Nu
m
be
r
D
C 
Nu
m
be
r
1,400,000
1,200,000
1,000,000
800,000
600,000
400,000
200,000
0
120,000
100,000
80,000
60,000
40,000
20,000
0
1,200,000
1,000,000
800,000
600,000
400,000
200,000
60,000
50,000
40,000
30,000
20,000
10,000
0
0
(b)
Ad
he
re
nt
 c
el
ls
Ad
he
re
nt
 c
el
ls
(c)
(d)
Control MgCl0.1mmol/L MgCl1mmol/L MgCl10 mmol/L
Control MgCl0.1mmol/L MgCl1mmol/L MgCl10 mmol/L
Control Mg (pure) MgCa 0.6 MgCa 0.8 MgCa 1.0 MgCa 1.2
Control Mg (pure) MgCa 0.6 MgCa 0.8 MgCa 1.0 MgCa 1.2
∗∗∗
∗ ∗
∗ ∗
∗
∗
∗ ∗∗
Figure 1. Dendritic cell (a) and macrophage (b) number after 6-day culture with
increasing concentrations of MgCl2 or after 6-day culture in degraded media (c, d). There is
a dose dependent decrease of dendritic cell numbers and an increase of macrophages with
increasing concentration of MgCl2 and with increasing concentrations of calcium in the
alloys. *p50.05, **p50.01, ***p50.001, n¼ 5.
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alloy media. Again, the positive control (LPS) induced a distinct increase
in CD86/CD11c double-positive cells (Table 2).
Mixed Leukocyte Reaction after Incubation with Magnesium/
Calcium Salts or Alloys
The mixed leukocyte reaction is a parameter for T-cell activation by
allogeneic DC. Again, an incubation of DC with magnesium chloride or
with degraded alloy media over 5 days did not enhance the allogeneic
T-cell proliferation (Table 1). Only high concentrations of CaCl2
(10mmol/L) led to a pronounced increase of T-cell proliferation.
However, this (unphysiological) high concentration also led to enhanced
DC apoptosis (Table 1).
Increased DC Migration with Increasing Magnesium and
Calcium Concentrations
There was an increase of DC migration, which became significant at
the highest concentration (10mmol/L). Again, the degraded alloys
induced an increased DC migration in alloys with the highest calcium
concentrations (Figure 2). Lead (PbCl2) was taken as a positive control
as it was described that lead induces an increased DC migration [19].
Table 2. CD86 expression on dendritic cell and concentration
of TNFa in supernatants of DC incubated with magnesium
chloride and calcium chloride or with degraded alloy media
over six days or with LPS (500 ng/mL) for 24 h, meanSD of
four independent experiments. ap50.01 compared to control.
Incubation with TNFa (pg/mL)
CD11c/CD86
positive cells (%)
Vehicle (control) 44 31 7.1 1.2
LPS 693 195a 24.8 11.7a
MgCl 0.1 mmol/L 117 56 7.4 0.8
MgCl 1 mmol/L 109 75 6.8 2.1
MgCl 10 mmol/L 123 72 7.9 3.1
CaCl 0.1 mmol/L 99 56 8.9 2.7
CaCl 1 mmol/L 112 41 7.7 3.3
CaCl 10 mmol/L 103 20 7.8 1.2
MgP 62 30 7.0 1.6
MgCa 0.6 66 34 5.3 2.2
MgCa 0.8 68 37 8.3 3.0
MgCa 1.0 87 27 10.2 3.8
MgCa 1.2 80 39 9.0 3.9
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DISCUSSION
Magnesium-based materials were first introduced as orthopedic bioma-
terials in the first half of the last century. However, the basic problem
was that puremagnesiummetal corroded too rapidly in vivo by producing
a large amount of gas which resulted in subcutaneous bubbles [1].
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Figure 2. Dendritic cell migration measured in a transwell system. There is a significant
increase in dendritic cell migration with the highest concentration ofMgCl2 ((a) 10mmol/L),
CaCl2 ((b) 10mmol/L, B), and degradationmedia (c). Lead (PbCl2 100 mmol/L) was taken as a
positive control. *p50.05, **p50.01, ***p50.001, n¼ 9, pooled from three independent
experiments.
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This fast corrosion is enhanced by the physiological pH of 7.4 and the high
chloride environment of the physiological system. It is intended to modify
the degradation time by addition of calcium to the magnesium alloys and
also to have a positive impact on stability criteria [4].
Most important is that the amount of liberatedmagnesium in the direct
environment of the degrading magnesium alloy has to be estimated.
Whereas Mgþþ deficiency is accompanied by a range of clinical symptoms
Mgþþ toxicity seems to be extremely rare. First side-effects occur at total
plasma Mgþþ of 3.5–5mmol/L and severe side-effects leading to heart
arrest occur only at extremely high plasma concentrations of 5–15mmol/L
[20]. Thus, a systemic effect can nearly be excluded as the level of
magnesium in the extracellular fluid ranges between 0.7 and 1.05mmol/L
[20] and a quite tight homeostasis is maintained by the kidneys and
intestine. A hyper-magnesiemia is rare due to the efficient excretion of the
element in the urine [20]. Our results obtained bymicrodialysis technique
indicate that concentrations of 3.7 (1.0) mmol/L (meanSD) can be
achieved after an incubation time of five hours in the direct environment
of a pure magnesium alloy (S. Schumacher, personal communication).
This microdialysis study was performed in the skin of eight isolated
perfused udders as described earlier [21]. These results correspond to the
maximum concentration found in alloy degradation media (Table 3) with
about 3–4mmol/L. When degradation media were analyzed, the increase
of the calcium concentration was always50.2mmol/L.
There are two results that warrant further examination. First, the
influence of Mgþþ on the DC development. There seems to be a favor for
macrophage development in an environment of higher Mgþþ levels.
Whether this has any physiological relevance has to be determined
in vivo, for example, by differential staining of macrophages and DC at
the site of implantation. Second, the enhanced DC migration. Although
this phenomenon is quite moderate, it is a robust, reproducible finding.
This also has to be determined in different settings, for example, DC
migration assays in vivo. The enhanced apoptosis and T-cell
Table 3. Concentration of Mg (mmol/L) in degraded media (n¼ 8
each group), which was taken for dendritic cell incubation.
MgP MgCa 0.6 MgCa 0.8 MgCa 1.0 MgCa 1.2
Minimum 0.42 1.07 0.77 0.95 0.68
25% Percentile 0.54 1.20 1.07 1.08 1.12
Median 1.00 1.28 1.29 1.38 1.47
75% Percentile 1.57 1.63 1.59 2.89 1.95
Maximum 1.64 1.74 1.74 3.48 2.08
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proliferation induced by the high CaCl2 concentration (10mmol/L) is not
of (patho) physiological relevance, as these concentrations will not be
achieved even with alloys containing higher calcium concentrations.
Taken together a new in vitro testing battery for possible immunotox-
icological effects was established with murine bone marrow-derived DC.
End points for DC function were viability (Annexin V/propidium iodide
assay), DC migration (transwell system), DC activation (TNFa secretion
and CD86 expression) and T-cell activation (mixed leukocyte reaction).
Incubation of DC with degradation media over 6 days had no influence on
cell viability and only marginal influence on DC migration. Also, the produ-
ction of TNFa and CD86 was not significantly enhanced by incubation
with degraded magnesium alloys. The mixed leukocyte reaction showed
no increase of the T-cell proliferation in comparison to untreated
controls. Only artificial high concentrations of calcium increased the
mixed leukocyte reaction. The positive controls (LPS stimulation,
incubation with etoposide, PbCl2 as chemoattractant) led to expected
reactions and activation in DC. As the incubation with increasing concen-
trations of magnesium and calcium chloride did also fail to influence the
above mentioned parameters it can be concluded that degradable
magnesium alloys tested might only have influence on DC migration.
However, if an enhancedmigration is associated with a biological relevant
activation of DC it must be verified in adequate in vivo experiments.
CONCLUSION
Mg–Ca alloys are promising new degradable alloys with excellent
biocompatibility. The present study demonstrate that Mgþþ and Caþþ
from degraded alloys do not significantly interfere with DC functions in
those concentrations anticipated by in vitro degradation experiments.
NOMENCLATURE
Al ¼ Aluminum
Ca ¼ Calcium
CD ¼ Cluster of differentiation
CFSE ¼ Carboxyfluorescein succinimidyl ester
Cr ¼ Cromnium
DC ¼ Dendritic cells
IL ¼ Interleukin
Mg ¼ Magnesium
Ti ¼ Titanium
TNFa ¼ Tumor necrosis factor a
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